Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
Zydus Lifesciences hikes share buyback price to Rs 1,260 per share, lowers share countZydus Lifesciences increased its share buyback price to Rs 1,260 per share while reducing the repurchase size to 87.3 lakh shares. The tota...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
Bond yields, FIIs and corporate actions among 8 factors to steer D-Street this weekNifty closed marginally higher last week, driven by IT and energy stocks, as markets brace for key events. Technical analysts suggest Nifty...
Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
Stocks in news: Lenskart, Apollo Hospitals, ZEE, BPCL, HindalcoIndian markets navigated a sideways trend, with analysts urging caution until the 24,000 mark is reclaimed. Key stocks like Lenskart, Apoll...
Two Trades for Today: A top life insurer for a gain of 7.8%, a mid-cap pharma stock for a rise of almost 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata MotorsIndian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
Zydus Life cleared to sell life-saving cancer drug; SC tells Bristol Myers to map patentsThe Supreme Court has provided Zydus Lifesciences with the go-ahead to launch its cancer drug biosimilar, countering efforts by Bristol Mye...
Zydus Life shares rise 2% after USFDA nod for Eluxadoline tabletsZydus Lifesciences shares rose nearly 2% to Rs 899.40 after receiving USFDA approval to manufacture Eluxadoline Tablets (75 mg & 100 mg) fo...
Hot stocks: Brokerage view on Bajaj Auto, KEI Industries, Zydus Life and L&T TechMacquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, raising its targ...
Jefferies upgrades Zydus Life to 'Buy' on strong US pipeline potential, stock up 4%Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a 'Buy' rating, citing the strength of the company’s US pipeline as a ma...
Hot stocks: Brokerage view on Reliance, Apollo Hospitals, Zydus Life and L&TSeveral brokerage firms provided ratings on notable companies. CLSA rated Reliance as Outperform with a Rs 3,300 target. Nomura downgraded ...
Time to buy pharma? 3 stocks Forum Parekh is betting onZydus Life's US business is going to report a good set of numbers. Also, in India, wellness products are doing good, Overall Zydus Life wil...
Hot Stocks: Brokerage view on Phoenix Mills, Anupam Rasayan; CLSA downgrades DelhiveryCLSA downgraded Delhivery to underperform, Jefferies raised Zydus Life target, and Anupam Rasayan had balance sheet concerns. Citigroup rec...
Hot Stocks: Brokerages on Zydus Life, PB Fintech, GAIL India and Bharat ElectronicsGovt has kept prices unchanged at $8.6/mmbtu for now. Continued delay could create a near-term overhang for the city gas distribution (CGD)...